Please login to the form below

Not currently logged in
Email:
Password:

Large antibody order for AbD Serotec

Proteomika SL has placed a large order for multi research antibodies with MorphoSys AG's AbD Serotec business unit.

Proteomika SL has placed a large order for multi research antibodies with MorphoSys AG's AbD Serotec business unit.

The Spanish biotech company, which specialises in biomarker technology, will be taking advantage of MorphoSys AG's HuCAL Gold (a powerful antibody library) based novel research antibodies.

This order will rank Proteomika, which is actively involved in cancer research/discovery programmes, as one of MorphoSys AG's largest customers

Dr Simon Moroney, CEO of MorphoSys AG, said: "This order is one of the largest generated by AbD Serotec, and highlights the advantage of our HuCAL technology in bespoke proteomics applications.

"We welcome the decision of Proteomika to use HuCAL Gold research antibodies in its proteomics programs."

A subsidiary of Progenika Biopharma SA, Proteomika was set up to exploit advances in biomarker research for the development of diagnostic and prognostic products.

Since its creation in 2002, the firm has established research collaborations with pharma and biotech companies aiming to validate non-invasive diagnostic and pharmacoproteomics.

Dr Laureano Simon, CEO of Proteomika, said: "The fast turn around in antibody production offered by AbD Serotec, together with the high quality of the resulting antibodies, will help accelerate the process of biomarker identification and validation."

Neither company involved in the deal has released financial details of the agreement.

5th March 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Creative Medical Research

Specialising in medical device market research and participant recruitment human factors research, our approach is people-centric. We thrive on making...

Latest intelligence

segmentation_pie_thumb.jpg
If you’re not thinking segmentation, you’re not thinking
Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked
...

Infographics